Ohm JE - Search Results

1

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP. Amann J, et al. Among authors: ohm je. Cancer Res. 2005 Jan 1;65(1):226-35. Cancer Res. 2005. PMID: 15665299

2

Immune dysfunction in cancer patients.

Ohm JE, Carbone DP. Ohm JE, et al. Oncology (Williston Park). 2002 Jan;16(1 Suppl 1):11-8. Oncology (Williston Park). 2002. PMID: 11829278 Free article. Review.

3

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.

Lee CT, Park KH, Yanagisawa K, Adachi Y, Ohm JE, Nadaf S, Dikov MM, Curiel DT, Carbone DP. Lee CT, et al. Among authors: ohm je. Cancer Res. 2004 Sep 15;64(18):6660-5. doi: 10.1158/0008-5472.CAN-04-1200. Cancer Res. 2004. PMID: 15374981

4

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.

Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP. Gabrilovich DI, et al. Among authors: ohm je. Clin Cancer Res. 1999 Oct;5(10):2963-70. Clin Cancer Res. 1999. PMID: 10537366

5

VEGF as a mediator of tumor-associated immunodeficiency.

Ohm JE, Carbone DP. Ohm JE, et al. Immunol Res. 2001;23(2-3):263-72. doi: 10.1385/IR:23:2-3:263. Immunol Res. 2001. PMID: 11444391 Review.

6

Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.

Adachi Y, Lee CT, Coffee K, Yamagata N, Ohm JE, Park KH, Dikov MM, Nadaf SR, Arteaga CL, Carbone DP. Adachi Y, et al. Among authors: ohm je. Gastroenterology. 2002 Oct;123(4):1191-204. doi: 10.1053/gast.2002.36023. Gastroenterology. 2002. PMID: 12360481

7

Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.

Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP. Dikov MM, et al. Among authors: ohm je. J Immunol. 2005 Jan 1;174(1):215-22. doi: 10.4049/jimmunol.174.1.215. J Immunol. 2005. PMID: 15611243

8

Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.

Ohm JE, Shurin MR, Esche C, Lotze MT, Carbone DP, Gabrilovich DI. Ohm JE, et al. J Immunol. 1999 Sep 15;163(6):3260-8. J Immunol. 1999. PMID: 10477595

9

VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.

Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, Carbone DP. Ohm JE, et al. Blood. 2003 Jun 15;101(12):4878-86. doi: 10.1182/blood-2002-07-1956. Epub 2003 Feb 13. Blood. 2003. PMID: 12586633 Free article.

10

Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine.

Amann JM, Chyla BJ, Ellis TC, Martinez A, Moore AC, Franklin JL, McGhee L, Meyers S, Ohm JE, Luce KS, Ouelette AJ, Washington MK, Thompson MA, King D, Gautam S, Coffey RJ, Whitehead RH, Hiebert SW. Amann JM, et al. Among authors: ohm je. Mol Cell Biol. 2005 Nov;25(21):9576-85. doi: 10.1128/MCB.25.21.9576-9585.2005. Mol Cell Biol. 2005. PMID: 16227606 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page